Business Context and Reporting Period
This Form 8-K was filed by AIT Therapeutics, Inc. (not Beyond Air, Inc.) on May 10, 2018. The registrant is a Delaware corporation headquartered in Harrison, NY, and is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance change rather than financial performance.
Material Changes
- Fiscal Year Change: The Board of Directors approved a change in the Company's fiscal year end from December 31 to March 31, effective March 31, 2018.
- Transition Period: A transition period of three months (January 1, 2018, to March 31, 2018) was established.
Guidance, Outlook, and Risks
The filing does not contain management guidance, outlook, or specific risk factors. It notes the Company's intention to file a transition report on Form 10-KT covering the three-month transition period on or prior to August 8, 2018.
Investor Verification Checklist
- Verify the upcoming Form 10-KT filing for the transition period ending March 31, 2018.
- Confirm the new fiscal year-end date of March 31 for future reporting cycles.
- Note the discrepancy between the requested company name (Beyond Air, Inc.) and the actual registrant (AIT Therapeutics, Inc.).